TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
73.90
+0.80 (1.09%)
Apr 29, 2026, 1:30 PM CST

TTY Biopharm Company Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
2,5212,7732,6212,3572,222
Upgrade
Short-Term Investments
467.74309.02195.54326.86372.65
Upgrade
Cash & Short-Term Investments
2,9893,0822,8172,6842,595
Upgrade
Cash Growth
-3.02%9.41%4.93%3.44%1.12%
Upgrade
Accounts Receivable
1,5181,3541,3441,2271,138
Upgrade
Other Receivables
36.4623.1828.8129.6813.62
Upgrade
Receivables
1,5541,3771,3731,2571,151
Upgrade
Inventory
1,3891,2701,0961,039955.01
Upgrade
Prepaid Expenses
--79.0249.8946.96
Upgrade
Other Current Assets
76.8864.586.365.371.15
Upgrade
Total Current Assets
6,0095,7935,3705,0354,749
Upgrade
Property, Plant & Equipment
2,1992,2462,2872,4332,519
Upgrade
Long-Term Investments
2,2051,9401,5781,4961,432
Upgrade
Goodwill
247.9247.9---
Upgrade
Other Intangible Assets
177.27123.44164.01250.75124.9
Upgrade
Long-Term Deferred Tax Assets
65.858.5248.7147.163.72
Upgrade
Other Long-Term Assets
444.8453.25426.94337.89407.19
Upgrade
Total Assets
11,34810,8639,8759,6019,296
Upgrade
Accounts Payable
270.78326.16294.66289.4187.27
Upgrade
Short-Term Debt
7001,2001,4501,3701,711
Upgrade
Current Portion of Long-Term Debt
500400-418.85407.91
Upgrade
Current Portion of Leases
8.350.935.863.927.62
Upgrade
Current Income Taxes Payable
323.68228.8156.97149.52150.39
Upgrade
Current Unearned Revenue
53.734.3414.2333.1339.77
Upgrade
Other Current Liabilities
783.33672.18662.02652.62547.55
Upgrade
Total Current Liabilities
2,6402,8622,5842,9173,052
Upgrade
Long-Term Debt
-1004009.64.15
Upgrade
Long-Term Leases
7.410.23.053.0414.16
Upgrade
Pension & Post-Retirement Benefits
17.0117.5427.440.8152.6
Upgrade
Long-Term Deferred Tax Liabilities
363.19359.24318.75305.44260.52
Upgrade
Other Long-Term Liabilities
269.32.4435.8391.03146.23
Upgrade
Total Liabilities
3,2973,3523,3693,3673,529
Upgrade
Common Stock
2,4872,4872,4872,4872,487
Upgrade
Additional Paid-In Capital
317.56317.04316.62312.18311.88
Upgrade
Retained Earnings
4,4273,8883,1822,9252,568
Upgrade
Comprehensive Income & Other
7.1858.69-43.79-64.78-198.07
Upgrade
Total Common Equity
7,2386,7505,9415,6585,168
Upgrade
Minority Interest
812.93760.49564.8574.86599.38
Upgrade
Shareholders' Equity
8,0517,5116,5066,2335,767
Upgrade
Total Liabilities & Equity
11,34810,8639,8759,6019,296
Upgrade
Total Debt
1,2161,7111,8591,8052,145
Upgrade
Net Cash (Debt)
1,7731,371957.65878.78450
Upgrade
Net Cash Growth
29.36%43.11%8.97%95.28%6.52%
Upgrade
Net Cash Per Share
7.115.503.843.531.81
Upgrade
Filing Date Shares Outstanding
248.65248.65248.65248.65248.65
Upgrade
Total Common Shares Outstanding
248.65248.65248.65248.65248.65
Upgrade
Working Capital
3,3692,9312,7872,1181,698
Upgrade
Book Value Per Share
29.1127.1523.8922.7620.78
Upgrade
Tangible Book Value
6,8136,3795,7775,4085,043
Upgrade
Tangible Book Value Per Share
27.4025.6523.2321.7520.28
Upgrade
Land
902.9902.9902.9902.9902.9
Upgrade
Buildings
1,4951,4791,4611,4321,420
Upgrade
Machinery
1,4431,4461,4321,4181,359
Upgrade
Construction In Progress
71.530.598.9577.0995
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.